Literature DB >> 26659350

A Population-Based Gaussian Mixture Model Incorporating 18F-FDG PET and Diffusion-Weighted MRI Quantifies Tumor Tissue Classes.

Mathew R Divine1, Prateek Katiyar2, Ursula Kohlhofer3, Leticia Quintanilla-Martinez3, Bernd J Pichler4, Jonathan A Disselhorst1.   

Abstract

UNLABELLED: The aim of our study was to create a novel Gaussian mixture modeling (GMM) pipeline to model the complementary information derived from(18)F-FDG PET and diffusion-weighted MRI (DW-MRI) to separate the tumor microenvironment into relevant tissue compartments and follow the development of these compartments longitudinally.
METHODS: Serial (18)F-FDG PET and apparent diffusion coefficient (ADC) maps derived from DW-MR images of NCI-H460 xenograft tumors were coregistered, and a population-based GMM was implemented on the complementary imaging data. The tumor microenvironment was segmented into 3 distinct regions and correlated with histology. ANCOVA was applied to gauge how well the total tumor volume was a predictor for the ADC and (18)F-FDG, or if ADC was a good predictor of (18)F-FDG for average values in the whole tumor or average necrotic and viable tissues.
RESULTS: The coregistered PET/MR images were in excellent agreement with histology, both visually and quantitatively, and allowed for validation of the last-time-point measurements. Strong correlations were found for the necrotic (r = 0.88) and viable fractions (r = 0.87) between histology and clustering. The GMM provided probabilities for each compartment with uncertainties expressed as a mixture of tissues in which the resolution of scans was inadequate to accurately separate tissues. The ANCOVA suggested that both ADC and (18)F-FDG in the whole tumor (P = 0.0009, P = 0.02) as well as necrotic (P = 0.008, P = 0.02) and viable (P = 0.003, P = 0.01) tissues were a positive, linear function of total tumor volume. ADC proved to be a positive predictor of (18)F-FDG in the whole tumor (P = 0.001) and necrotic (P = 0.02) and viable (P = 0.0001) tissues.
CONCLUSION: The complementary information of (18)F-FDG and ADC longitudinal measurements in xenograft tumors allows for segmentation into distinct tissues when using the novel GMM pipeline. Leveraging the power of multiparametric PET/MRI in this manner has the potential to take the assessment of disease outcome beyond RECIST and could provide an important impact to the field of precision medicine.
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  18F-FDG; DWI; Gaussian mixture model; PET/MR

Mesh:

Substances:

Year:  2015        PMID: 26659350     DOI: 10.2967/jnumed.115.163972

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  13 in total

1.  A clinical-radiomics nomogram for the preoperative prediction of lung metastasis in colorectal cancer patients with indeterminate pulmonary nodules.

Authors:  TingDan Hu; ShengPing Wang; Lv Huang; JiaZhou Wang; DeBing Shi; Yuan Li; Tong Tong; Weijun Peng
Journal:  Eur Radiol       Date:  2018-06-12       Impact factor: 5.315

2.  Clustering approach to identify intratumour heterogeneity combining FDG PET and diffusion-weighted MRI in lung adenocarcinoma.

Authors:  Jonghoon Kim; Seong-Yoon Ryu; Seung-Hak Lee; Ho Yun Lee; Hyunjin Park
Journal:  Eur Radiol       Date:  2018-06-19       Impact factor: 5.315

Review 3.  CT Radiomics in Thoracic Oncology: Technique and Clinical Applications.

Authors:  Geewon Lee; So Hyeon Bak; Ho Yun Lee
Journal:  Nucl Med Mol Imaging       Date:  2017-12-18

Review 4.  Imaging Tumor Metabolism to Assess Disease Progression and Treatment Response.

Authors:  Kerstin N Timm; Brett W C Kennedy; Kevin M Brindle
Journal:  Clin Cancer Res       Date:  2016-09-08       Impact factor: 12.531

5.  Use of an optimised enzyme/prodrug combination for Clostridia directed enzyme prodrug therapy induces a significant growth delay in necrotic tumours.

Authors:  Alexandra M Mowday; Ludwig J Dubois; Aleksandra M Kubiak; Jasmine V E Chan-Hyams; Christopher P Guise; Amir Ashoorzadeh; Philippe Lambin; David F Ackerley; Jeff B Smaill; Nigel P Minton; Jan Theys; Adam V Patterson
Journal:  Cancer Gene Ther       Date:  2021-02-08       Impact factor: 5.987

6.  A Novel Unsupervised Segmentation Approach Quantifies Tumor Tissue Populations Using Multiparametric MRI: First Results with Histological Validation.

Authors:  Prateek Katiyar; Mathew R Divine; Ursula Kohlhofer; Leticia Quintanilla-Martinez; Bernhard Schölkopf; Bernd J Pichler; Jonathan A Disselhorst
Journal:  Mol Imaging Biol       Date:  2017-06       Impact factor: 3.488

Review 7.  Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research.

Authors:  Marcello Mancini; Paul Summers; Francesco Faita; Maurizia R Brunetto; Francesco Callea; Andrea De Nicola; Nicole Di Lascio; Fabio Farinati; Amalia Gastaldelli; Bruno Gridelli; Peppino Mirabelli; Emanuele Neri; Piero A Salvadori; Eleni Rebelos; Claudio Tiribelli; Luca Valenti; Marco Salvatore; Ferruccio Bonino
Journal:  World J Hepatol       Date:  2018-02-27

8.  Linking imaging to omics utilizing image-guided tissue extraction.

Authors:  Jonathan A Disselhorst; Marcel A Krueger; S M Minhaz Ud-Dean; Ilja Bezrukov; Mohamed A Jarboui; Christoph Trautwein; Andreas Traube; Christian Spindler; Jonathan M Cotton; Dieter Leibfritz; Bernd J Pichler
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-05       Impact factor: 11.205

9.  An Automated Segmentation Pipeline for Intratumoural Regions in Animal Xenografts Using Machine Learning and Saturation Transfer MRI.

Authors:  Wilfred W Lam; Wendy Oakden; Elham Karami; Margaret M Koletar; Leedan Murray; Stanley K Liu; Ali Sadeghi-Naini; Greg J Stanisz
Journal:  Sci Rep       Date:  2020-05-15       Impact factor: 4.379

10.  Associations between apparent diffusion coefficient values and histopathological tissue alterations in myopathies.

Authors:  Hans-Jonas Meyer; Ilka Schneider; Alexander Emmer; Malte Kornhuber; Alexey Surov
Journal:  Brain Behav       Date:  2020-08-29       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.